Article Details
Retrieved on: 2024-08-02 14:36:54
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(NYSE: NYSE:INSP), a company specializing in medical technology for obstructive sleep apnea (OSA) treatment, has received FDA approval for its Inspire ...
Article found on: www.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here